Michael Matson
Stock Analyst at Needham
(2.61)
# 2,104
Out of 5,113 analysts
23
Total ratings
69.23%
Success rate
11.46%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Buy | $408 → $423 | $104.44 | +305.02% | 4 | Jan 31, 2020 | |
| INGN Inogen | Upgrades: Buy | $90 | $5.85 | +1,438.46% | 2 | Nov 6, 2019 | |
| MMSI Merit Medical Systems | Initiates: Buy | $53 | $81.29 | -34.80% | 1 | Apr 20, 2018 | |
| GMED Globus Medical | Upgrades: Buy | n/a | $91.00 | - | 1 | Apr 4, 2018 | |
| RMD ResMed | Upgrades: Hold | n/a | $258.03 | - | 1 | Jan 23, 2018 | |
| BSX Boston Scientific | Upgrades: Strong Buy | n/a | $93.81 | - | 1 | Dec 8, 2017 | |
| LIVN LivaNova | Upgrades: Buy | n/a | $63.86 | - | 2 | Sep 15, 2017 | |
| SYK Stryker | Upgrades: Hold | n/a | $356.83 | - | 4 | Aug 25, 2017 | |
| MBLY Mobileye Global | Downgrades: Hold | n/a | $9.82 | - | 1 | Mar 14, 2017 | |
| HOLX Hologic | Upgrades: Buy | n/a | $75.14 | - | 2 | Feb 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $89.45 | - | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.01 | - | 1 | Mar 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.09 | - | 1 | Feb 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $519.86 | - | 1 | Jan 29, 2016 |
Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408 → $423
Current: $104.44
Upside: +305.02%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $5.85
Upside: +1,438.46%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $81.29
Upside: -34.80%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $91.00
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $258.03
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $93.81
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $63.86
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $356.83
Upside: -
Mobileye Global
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $9.82
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $75.14
Upside: -
Aug 12, 2016
Downgrades: Hold
Price Target: n/a
Current: $89.45
Upside: -
Mar 3, 2016
Downgrades: Neutral
Price Target: n/a
Current: $1.01
Upside: -
Feb 24, 2016
Downgrades: Hold
Price Target: n/a
Current: $4.09
Upside: -
Jan 29, 2016
Upgrades: Buy
Price Target: n/a
Current: $519.86
Upside: -